Patent cliff continues to drive mergers in drug industry
March 30, 2015 at 14:50 PM EDT
A rash of mergers among pharmaceutical companies is driven by fears that a lack of innovation among drug makers.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.